MeiraGTx Holdings (MGTX) Capital Expenditures Growth (1y) (2018 - 2025)
MeiraGTx Holdings (MGTX) Capital Expenditures Growth (1y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
MeiraGTx Holdings |
910.47 Mn |
844.54 Mn |
74.89 Mn |
-77.67% |
| Date | Value |
|---|
| Dec 31, 2025 |
-77.67% |
| Sep 30, 2025 |
-16.44% |
| Jun 30, 2025 |
-7.15% |
| Mar 31, 2025 |
1.91% |
| Dec 31, 2024 |
-59.80% |
| Sep 30, 2024 |
-79.52% |
| Jun 30, 2024 |
-73.29% |
| Mar 31, 2024 |
-80.50% |
| Dec 31, 2023 |
-64.32% |
| Sep 30, 2023 |
-64.40% |
| Jun 30, 2023 |
-64.46% |
| Mar 31, 2023 |
-30.94% |
| Dec 31, 2022 |
-65.15% |
| Sep 30, 2022 |
-15.91% |
| Jun 30, 2022 |
151.12% |
| Mar 31, 2022 |
176.77% |
| Dec 31, 2021 |
204.04% |
| Sep 30, 2021 |
99.85% |
| Jun 30, 2021 |
91.19% |
| Mar 31, 2021 |
11.55% |
